Home Healthcare Gene Therapy Market
gene therapy market

Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Vector Type (Viral, Non-viral); By Approach (Gene Augmentation, Oncolytic Viral Therapy, Immunotherapy, Others); By Therapeutic Area; By Route of Administration; By Regions; Segment Forecast, 2021 - 2028

  • Published Date: Jan 2021
  • Pages: 132
  • Format: PDF
  • Report ID: PM1084
  • Base Year: 2020
  • Historical Data: 2016 - 2019

Report Scope

Gene Therapy Market, Therapeutic Area Outlook (Revenue - USD Million, 2016 – 2028)

  • Autoimmune Disorders
  • Cardiovascular Diseases
  • Dermatological Disorders
  • Genetic Disorders
  • Hematological Disorders
  • Metabolic Disorders
  • Muscle-related Diseases
  • Oncological Disorders
  • Ophthalmic Diseases
  • Others

Gene Therapy Market, Vector Type Outlook (Revenue - USD Million, 2016 – 2028)

  • Viral vectors
    • Retroviral vectors
      • Gamma-retroviral vectors
      • Lentiviral vectors
    • Adeno-associated virus vectors
    • other viral vectors
  • Non-viral Vectors
    • Oligonucleotides
    • Other non-viral vectors (plasmids and RNAi)

Gene Therapy Market, Approach Outlook (Revenue - USD Million, 2016 – 2028)

  • Gene Augmentation
  • Oncolytic Viral Therapy
  • Immunotherapy
  • Others

Gene Therapy Market, Route of Administration Outlook (Revenue - USD Million, 2016 – 2028)

  • Intraarticular
  • Intracerebellar
  • Intradermal
  • Intramuscular
  • Intratumoral
  • Intravenous
  • Intravesical
  • Intravitreal
  • Subretinal
  • Others

Gene Therapy Market, Regional Outlook (Revenue - USD Million, 2016 – 2028)

  • North America
    • Therapeutic Area Outlook
      • Autoimmune Disorders
      • Cardiovascular Diseases
      • Dermatological Disorders
      • Genetic Disorders
      • Hematological Disorders
      • Metabolic Disorders
      • Muscle-related Diseases
      • Oncological Disorders
      • Ophthalmic Diseases
      • Others
    • Vector Type Outlook
      • Viral vectors
        • Retroviral vectors
          • Gamma-retroviral vectors
          • Lentiviral vectors
        • Adeno-associated virus vectors
        • other viral vectors
      • Non-viral Vectors
        • Oligonucleotides
        • Other non-viral vectors (plasmids and RNAi)
    • Approach Outlook
      • Gene Augmentation
      • Oncolytic Viral Therapy
      • Immunotherapy
      • Others
    • Route of Administration Outlook
      • Intraarticular
      • Intracerebellar
      • Intradermal
      • Intramuscular
      • Intratumoral
      • Intravenous
      • Intravesical
      • Intravitreal
      • Subretinal
      • Others
  • Europe
    • Therapeutic Area Outlook
      • Autoimmune Disorders
      • Cardiovascular Diseases
      • Dermatological Disorders
      • Genetic Disorders
      • Hematological Disorders
      • Metabolic Disorders
      • Muscle-related Diseases
      • Oncological Disorders
      • Ophthalmic Diseases
      • Others
    • Vector Type Outlook
      • Viral vectors
        • Retroviral vectors
          • Gamma-retroviral vectors
          • Lentiviral vectors
        • Adeno-associated virus vectors
        • other viral vectors
      • Non-viral Vectors
        • Oligonucleotides
        • Other non-viral vectors (plasmids and RNAi)
    • Approach Outlook
      • Gene Augmentation
      • Oncolytic Viral Therapy
      • Immunotherapy
      • Others
    • Route of Administration Outlook
      • Intraarticular
      • Intracerebellar
      • Intradermal
      • Intramuscular
      • Intratumoral
      • Intravenous
      • Intravesical
      • Intravitreal
      • Subretinal
      • Others
  • Asia Pacific
    • Therapeutic Area Outlook
      • Autoimmune Disorders
      • Cardiovascular Diseases
      • Dermatological Disorders
      • Genetic Disorders
      • Hematological Disorders
      • Metabolic Disorders
      • Muscle-related Diseases
      • Oncological Disorders
      • Ophthalmic Diseases
      • Others
    • Vector Type Outlook
      • Viral vectors
        • Retroviral vectors
          • Gamma-retroviral vectors
          • Lentiviral vectors
        • Adeno-associated virus vectors
        • other viral vectors
      • Non-viral Vectors
        • Oligonucleotides
        • Other non-viral vectors (plasmids and RNAi)
    • Approach Outlook
      • Gene Augmentation
      • Oncolytic Viral Therapy
      • Immunotherapy
      • Others
    • Route of Administration Outlook
      • Intraarticular
      • Intracerebellar
      • Intradermal
      • Intramuscular
      • Intratumoral
      • Intravenous
      • Intravesical
      • Intravitreal
      • Subretinal
      • Others
  • Latin America
    • Therapeutic Area Outlook
      • Autoimmune Disorders
      • Cardiovascular Diseases
      • Dermatological Disorders
      • Genetic Disorders
      • Hematological Disorders
      • Metabolic Disorders
      • Muscle-related Diseases
      • Oncological Disorders
      • Ophthalmic Diseases
      • Others
    • Vector Type Outlook
      • Viral vectors
        • Retroviral vectors
          • Gamma-retroviral vectors
          • Lentiviral vectors
        • Adeno-associated virus vectors
        • other viral vectors
      • Non-viral Vectors
        • Oligonucleotides
        • Other non-viral vectors (plasmids and RNAi)
    • Approach Outlook
      • Gene Augmentation
      • Oncolytic Viral Therapy
      • Immunotherapy
      • Others
    • Route of Administration Outlook
      • Intraarticular
      • Intracerebellar
      • Intradermal
      • Intramuscular
      • Intratumoral
      • Intravenous
      • Intravesical
      • Intravitreal
      • Subretinal
      • Others
  • Middle East & Africa
    • Therapeutic Area Outlook
      • Autoimmune Disorders
      • Cardiovascular Diseases
      • Dermatological Disorders
      • Genetic Disorders
      • Hematological Disorders
      • Metabolic Disorders
      • Muscle-related Diseases
      • Oncological Disorders
      • Ophthalmic Diseases
      • Others
    • Vector Type Outlook
      • Viral vectors
        • Retroviral vectors
          • Gamma-retroviral vectors
          • Lentiviral vectors
        • Adeno-associated virus vectors
        • other viral vectors
      • Non-viral Vectors
        • Oligonucleotides
        • Other non-viral vectors (plasmids and RNAi)
    • Approach Outlook
      • Gene Augmentation
      • Oncolytic Viral Therapy
      • Immunotherapy
      • Others
    • Route of Administration Outlook
      • Intraarticular
      • Intracerebellar
      • Intradermal
      • Intramuscular
      • Intratumoral
      • Intravenous
      • Intravesical
      • Intravitreal
      • Subretinal
      • Others

Qualitative Analysis

  • Industry overview
    • Industry trends
    • Market drivers and restraints
    • Market size
    • Growth prospects
    • Porter’s analysis
    • PESTEL Analysis
    • Value Chain Analysis
    • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments
    • Price Trend Analysis

Quantitative Analysis

  • Market size, estimates, and forecasts from 2016 - 2028
  • Market size and revenue estimates for application up to 2028
  • Market revenue estimates for type up to 2028
  • Market revenue estimates for end-use up to 2028
  • Regional market size and forecast up to 2028
  • Company financials
Polaris Market Research
Gene Therapy Market Size, Share - Global Industry Growth Report 2028